An 83-year-old patient with RET fusion-positive non-small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration.
Respirol Case Rep
; 11(5): e01136, 2023 May.
Article
en En
| MEDLINE
| ID: mdl-37051304
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
Respirol Case Rep
Año:
2023
Tipo del documento:
Article